Polar Research and Supply Vessel POLARSTERN Operated by the Alfred-Wegener-Institute
Journal of large-scale research facilities JLSRF · 16.10.2017 · 3 · A119
DOI: 10.17815/jlsrf-3-163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of large-scale research facilities JLSRF, online erschienen am 16.10.2017. Verfasst von Rainer Knust. Die Arbeit wurde bisher 185-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
POLARSTERN, operated by the Alfred-Wegener-Institut Helmholtz-Zentrum für Polar- und Meeresforschung, is an ice going research and supply vessel. The main operation areas are the ice-covered seas of the northern and southern polar regions. The ship provides ideal working conditions for almost all compartments of marine sciences, atmospheric and glaciological research. It can break ice up to 2m continuously and can operate up to 90 days at sea. POLARSTERN is therefore ideally suited for often long expeditions to remote Polar Regions. POLARSTERN regularly supplies the Antarctic research stations, especially the Neumayer Station III and the Kohnen Station (Alfred-Wegener-Institut Helmholtz-Zentrum für Polar- und Meeresforschung, 2016a). In the last 30 years POLARSTERN was in average 310 days per year at sea, she is the major research tool of the German polar research programme.
Zitieren
APA
Knust, R. (2017). Polar Research and Supply Vessel POLARSTERN Operated by the Alfred-Wegener-Institute. Journal of large-scale research facilities JLSRF, 3, A119. https://doi.org/10.17815/jlsrf-3-163
Vancouver
Knust R. Polar Research and Supply Vessel POLARSTERN Operated by the Alfred-Wegener-Institute. Journal of large-scale research facilities JLSRF. 2017;3:A119. doi:10.17815/jlsrf-3-163
BibTeX
@article{Knust2017,
author = {Knust, Rainer},
title = {Polar Research and Supply Vessel POLARSTERN Operated by the Alfred-Wegener-Institute},
journal = {Journal of large-scale research facilities JLSRF},
year = {2017},
volume = {3},
pages = {A119},
doi = {10.17815/jlsrf-3-163}
}
EUVIMED